Skip to main content
SpringerLink
Log in

Sarcoma

Patient-derived organoids unveil sarcoma vulnerabilities

  • Journal Club
  • Published:

From Nature Reviews Cancer

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Original article

  • Calandrini, C. et al. Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors. Cell Rep. 36, 109568 (2021)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. International Research Center, A.C. Camargo Cancer Center, São Paulo, Brazil

    Tiago Góss dos Santos

Authors
  1. Tiago Góss dos Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tiago Góss dos Santos.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Góss dos Santos, T. Patient-derived organoids unveil sarcoma vulnerabilities. Nat Rev Cancer 24, 166 (2024). https://doi.org/10.1038/s41568-023-00661-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41568-023-00661-8

  • Springer Nature Limited

Search

Navigation